Art

J-GLOBAL ID：202102231971106767   Reference number：21A0191895

頭頸部癌患者の免疫とがん免疫療法の展望

Author (1)： SAKURAI DAIJU (山梨大 大学院総合研究部 医学域 耳鼻咽喉科・頭頸部外科)
Material： 耳鼻咽喉科展望  (Oto-Rhino-Laryngology, Tokyo)
Volume： 63  Issue： 6  Page： 258-265  Publication year： Dec. 2020 
JST Material Number： Z0542B  ISSN： 0386-9687  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human ,...
Semi thesaurus term： Natural Killer T-Cell ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0191895&from=J-GLOBAL&jstjournalNo=Z0542B") }}

JST classification (2)： Tumors(=neoplasms)of ear,nose,pharynx and larynx  (GQ04000E) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (40)：

• 1) Global Burden of Disease Cancer Collaboration; Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol 3: 524-548, 2017.
• 2) Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, et al: The global incidence of lip, oral cavity, and pharyngeal cancers by subsitein 2012. CA. Cancer J Clin 67: 51-64, 2017.
• 3) Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, et al: Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N Engl J Med 375: 1856-1867, 2016.
• 4) Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, et al: Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral Oncol 81: 45-51, 2018.
• 5) Subramaniam SS, Paterson C, McCaul JA: Immunotherapy in the management of squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg 57: 957-966, 2019.

Terms in the title (5)： 頭頸部 ,  癌患者 ,  免疫 ,  がん免疫療法 ,  展望